Patent Yard Sign in
Expired Canadian patentCanada

Improved activation of recombinant proteins

CA 2061569 C · Owner: Boehringer Mannheim Gmbh · Inventors: Rudolph, Rainer; Ambrosius, Dorothea; Dony, Carola

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A process for the activation of recombinant proteins which are present in at least a partially inactive form in which a protein is activated by known solubilization or/and renaturation techniques, said protein having additional helper sequences 2 to 50 amino acids in length at its N- or/and C-terminus whereby the relative hydrophobicity of these helper sequences which is calculated as the sum of the relative hydrophobicity specified in Table 1 for the individual amino acids has a negative numerical value.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 20, 1992 and granted October 24, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 20, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 20, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 20, 1992
GrantedOctober 24, 2000
Term endedFebruary 20, 2012
Patent numberCA 2061569 C
Classification (IPC)C12P21/06 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedFeb 20, 1992Patent grantedOct 24, 2000Term endedFeb 20, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.